ARUP LABORATORIES, INC.

Budget/Appropriations

Monitor the following: Public Law 117-328, Consolidated Appropriations Act, FY2023, Lab Infrastructure issues; and Diagnostic Lab Testing related issues Public Law 119-21, One Big Beautiful Bill Act, generally

Health Issues

H.R.3152/S.1546, Patent Eligibility Restoration Act of 2025, Laboratory technology related issues FDA regulation, Laboratory Testing related issues Clinical Laboratory Improvement Amendments (CLIA), Modernization generally H.R.5269/S.2761, Reforming and Enhancing Sustainable Updates to Laboratory Testing Services Act of 2025 (RESULTS Act), Entirety Monitor the following: Possible Reconciliation, FY2026, Health related provisions Possible Health policy package Prescription drug costs, generally VALID Act, Diagnostic Lab Testing Public Law 117-328, Consolidated Appropriations Act, FY2023, Lab Infrastructure issues; and Diagnostic Lab Testing related issues Public Health reporting initiatives

TargetedSENATE

Medical/Disease Research/Clinical Labs

H.R.3152/S.1546, Patent Eligibility Restoration Act of 2025, Laboratory technology related issues FDA regulation, Laboratory Testing related issues Clinical Laboratory Improvement Amendments (CLIA), Modernization generally H.R.5269/S.2761, Reforming and Enhancing Sustainable Updates to Laboratory Testing Services Act of 2025 (RESULTS Act), Entirety Monitor the following: Possible Reconciliation, FY2026, Health related provisions Possible Health policy package Prescription drug costs, generally VALID Act, Diagnostic Lab Testing Public Law 117-328, Consolidated Appropriations Act, FY2023, Lab Infrastructure issues; and Diagnostic Lab Testing related issues Public Health reporting initiatives